David J. Wambeke, Chief Business Officer: DiaMedica Therapeutics DMAC Buy · Filed 23/11/16

Trade details

Type: Insider buy
Amount: $49,200
Shares · price: 20,000 sh · $2.46 a share
Held after: 527,114 sh
Stock: DiaMedica Therapeutics DMAC
Person: David J. WambekeChief Business Officer
Trade date: 23/11/16
Filed: 23/11/16
Days to filing: 0 days

Holdings up 3.9%

Insiders buying this week: 1 insiders
Holding change: +3.9%

DiaMedica Therapeutics trades, last 26 weeks

What else happened in DiaMedica Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/17~23/12/16

David J. Wambeke's recent trades

David J. WambekeChief Business Officer
BuyNeuroone Medical Technologies
Buy
Neuroone Medical Technologies
NMTC
$670K
1,000,000 sh
$670K
Filed 03/03
Traded 03/01
David J. WambekeChief Business Officer
BuyDiaMedica Therapeutics
Buy
DiaMedica Therapeutics
DMAC
$150K
38,364 sh
$150K
Filed 23/06/26
Traded 23/06/23
David J. WambekeChief Business Officer
BuyDiaMedica Therapeutics
Buy
DiaMedica Therapeutics
DMAC
$750K
468,750 sh
$750K
Filed 23/04/11
Traded 23/04/10